BI
BML Investment Partners, L.P. disclosed a 6.8% stake in CNTB
BML Investment Partners, L.P. reported owning 6.8% of Connect Biopharma Holdings Ltd (CNTB) (4,264,400 shares) in a Schedule 13G filed Oct 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 6, 2026
- Source
- Schedule 13G